NDC 0781-9124-85 - Nafcillin

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
0781-9124
Requested NDC
0781-9124-85
Package NDCs from labels
0781-9124-85, 0781-9124-95
Manufacturer
Sandoz Inc
Effective date
2020-12-15
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
Nafcillin - Sandoz IncSandoz Inc2020-12-15HUMAN PRESCRIPTION DRUG LABEL
National Council for Prescription Drug Programs indexing - billing unitNational Council for Prescription Drug Programs2012-07-24Indexing - Billing Unit

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0781-9124-85EA - Each0781-9124ccfe698c-a133-4231-8643-63cc9871e04712012-07-24
0781-9124-95EA - Each0781-91249e7a5e74-9ab4-470d-b8ab-1f1fb162d2b812012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
NAFCILLIN SODIUMACTIVE INGREDIENT49G3001BCKNAFCILLIN INJECTION, POWDER, FOR SOLUTION [SANDOZ INC]13
NAFCILLINACTIVE MOIETY4CNZ27M7RVNAFCILLIN INJECTION, POWDER, FOR SOLUTION [SANDOZ INC]13
SODIUM CITRATEINACTIVE INGREDIENT1Q73Q2JULRNAFCILLIN INJECTION, POWDER, FOR SOLUTION [SANDOZ INC]13

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 3 of 3 · 49 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
BSSBALANCED SALT SOLUTIONAlcon Laboratories, Inc.4bd4d59c-eb3b-4a5e-9eb7-ae95b0a92bea2024-01-25Warnings, Adverse reactionsExact identifier
unii: 1Q73Q2JULR
BSSBALANCED SALT SOLUTIONAlcon Laboratories, Inc.28488c7b-cf6a-4a03-916f-cc66b3afdc572023-12-14Warnings, Adverse reactionsExact identifier
unii: 1Q73Q2JULR
AddiclenzBETA VULGARIS, BOLDO, CHELIDONIUM MAJUS, PETROSELINUM SATIVUM, TARAXACUM OFFICINALE, ARSENICUM ALBUM, BISPHENOL A, COBALTUM METALLICUM, CUPRUM METALLICUM, GLYPHOSATE, IODIUM, LYCOPODIUM CLAVATUM, PHOSPHORICUM ACIDUM, SELENIUM METALLICUM, ZINCUM METALLICUM, ASPARTAME, BENZALKONIUM CHLORIDE, FORMALINUM, METHYLENE CHLORIDE, METHYL PARABEN, PROPYL PARABEN, SODIUM BENZOATE, SODIUM CITRATE, TITANIUM DIOXIDE, ZINCUM OXYDATUMDeseret Biologicals, Inc.e39235ea-2a2f-44a7-92d6-fb1d428ebabd2022-05-12WarningsExact identifier
unii: 1Q73Q2JULR
ACD-AANTICOAGULANT CITRATE DEXTROSE SOLUTION FORMULA AFenwal, Inc.22805f0d-ba58-41ea-b245-19980abcda222022-02-11Exact identifier
unii: 1Q73Q2JULR
0a37dc34-376e-4500-b3b1-20d91aa481e3c50a4dbd-534c-4639-a73f-5e0947d99a632020-12-15Warnings, Adverse reactionsExact identifier
spl set id: c50a4dbd-534c-4639-a73f-5e0947d99a63
NafcillinNAFCILLINFresenius Kabi USA, LLCbbf0d8e4-b8e4-4958-b6b6-f0b9960f3b6a2019-06-12Warnings, Adverse reactionsExact identifier
unii: 49G3001BCK
NafcillinNAFCILLIN SODIUMFresenius Kabi USA, LLC3c2581a1-8051-4d7a-a1f7-521248648dc92019-05-24Warnings, Adverse reactionsExact identifier
unii: 49G3001BCK
NafcillinNAFCILLIN SODIUMFresenius Kabi USA, LLCc39721a3-7b22-4720-9dbd-bc82f03d2af72019-05-17Warnings, Adverse reactionsExact identifier
unii: 49G3001BCK
AdditoxTRIFOLIUM PRATENSE, XANTHOXYLUM FRAXINEUM, PHYTOLACCA DECANDRA, ARSENICUM ALBUM, BELLADONNA, CHELIDONIUM MAJUS, LYCOPODIUM CLAVATUM, PHOSPHORICUM ACIDUM, ASPARTAME, BENZALKONIUM CHLORIDE, FORMALINUM, METHYLENE CHLORIDE, METHYLPARABEN, PROPYLPARABEN, SODIUM BENZOATE, SODIUM CITRATE, TITANIUM DIOXIDE, ZINCUM OXYDATUMBioActive Nutritional, Inc.319ee2fe-58e3-495e-bf0d-df201f6fbb1c2018-07-18WarningsExact identifier
unii: 1Q73Q2JULR

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.